Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 6Other hematologic neoplasm 3Lymphoid 2Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 394Precursor Cell Lymphoblastic Leukemia-Lymphoma 226Hematologic Neoplasms 206Leukemia, Lymphocytic, Chronic, B-Cell 175Myelodysplastic Syndromes 144Leukemia 125Lymphoma 90Lymphoma, Non-Hodgkin 76Multiple Myeloma 67Leukemia, Myelogenous, Chronic, BCR-ABL Positive 67Recurrence 55Neoplasms 53Leukemia, Myelomonocytic, Chronic 50Burkitt Lymphoma 44Lymphoma, Large B-Cell, Diffuse 41Leukemia, Biphenotypic, Acute 41Myeloproliferative Disorders 39Lymphoma, Mantle-Cell 39Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 37Hodgkin Disease 36Lymphoma, B-Cell 32Lymphoma, Follicular 31Leukemia, B-Cell 27Lymphoma, B-Cell, Marginal Zone 24Anemia, Refractory, with Excess of Blasts 24Waldenstrom Macroglobulinemia 23Primary Myelofibrosis 21Myelodysplastic-Myeloproliferative Diseases 20Hematologic Diseases 19Lymphoma, T-Cell 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Cardiotoxicity × Other hematologic neoplasm × 90 days × Clear all
NCT01212926 2026-05-28

CA2D

University Hospital, Bordeaux

Phase NA Completed
100 enrolled
Other hematologic neoplasm

Leukemia, Cardiotoxicity

NCT05598879 2026-05-12

G-COR

The Cleveland Clinic

Recruiting
5,000 enrolled
BreastOther hematologic neoplasm

Breast Neoplasms, Cardiovascular Diseases, Hematologic Neoplasms, Cardiotoxicity

NCT06211413 2026-03-23

SENTINEL

Abramson Cancer Center at Penn Medicine

Enrolling by invitation
50 enrolled
LymphoidOther hematologic neoplasm

Atrial Fibrillation, Hypertension, Leukemia, Lymphocytic, Chronic, B-Cell, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡